By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AlgoRx Pharmaceuticals, Inc. (Acquired by Parexel International) 

Press releases archived for reference only.
12A Powder Horn Hill
Wilton  Connecticut  06897  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Merger Creating Late-Stage Company Addressing Pain Management And Inflammation 12/16/2005 10:27:46 AM
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Enrollment For Phase 1/2 Trial Of Avrina(TM), New Drug Candidate For Eczema 12/6/2005 10:46:14 AM
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) To Webcast Presentation From The Lazard Capital Markets 2005 Life Sciences Conference 11/22/2005 10:53:38 AM
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. To Mail Definitive Proxy For Proposed Merger 11/17/2005 10:21:10 AM
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Addition Of Ninth Board Member To Proposed Board Of Directors For Combined Company 11/15/2005 10:46:40 AM
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Announce Positive Data From Second Of Two Phase 3 Trials Of ALGRX 3268 11/8/2005 10:32:57 AM
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) To Webcast Presentations From Two Upcoming Investor Conferences 11/2/2005 10:32:15 AM
Corgentech, Inc. (CGTK) And AlgoRx Pharmaceuticals, Inc. Complete Enrollment For Phase 1/2 Trial Of Avrina, New Drug Candidate For Eczema 10/27/2005 11:12:36 AM
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Positive Phase 2 Data In Patients With Morton's Neuroma10/19/2005 5:13:22 PM
AlgoRx Pharmaceuticals, Inc. And Corgentech, Inc. (CGTK) Announce Positive Data From Phase 3 Trial Of ALGRX 326810/19/2005 5:13:18 PM
123
//-->